Gastro Group of Rochester /ID# 166216

Rochester, New York 14618-5703

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy — Completed